MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 584239 | Name: BN 52115

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BN 52115 is a platelet activating factor antagonist that has been found to inhibit in vivo bronchopulmonary alteration.

Chemical Structure

BN 52115
BN 52115
CAS#120908-94-3

Theoretical Analysis

MedKoo Cat#: 584239

Name: BN 52115

CAS#: 120908-94-3

Chemical Formula: C37H60BrNO4

Exact Mass: 661.3706

Molecular Weight: 662.79

Elemental Analysis: C, 67.05; H, 9.13; Br, 12.06; N, 2.11; O, 9.66

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
BN 52115; BN-52115; BN52115
IUPAC/Chemical Name
Quinolinium, 1-(6-((2-heptadecyl-2-methyl-1,3-dioxolan-4-yl)methoxy)-6-oxohexyl)-, bromide
InChi Key
FTFOSFBACGPTIP-UHFFFAOYSA-M
InChi Code
InChI=1S/C37H60NO4.BrH/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-21-28-37(2)41-32-34(42-37)31-40-36(39)27-18-17-22-29-38-30-23-25-33-24-19-20-26-35(33)38;/h19-20,23-26,30,34H,3-18,21-22,27-29,31-32H2,1-2H3;1H/q+1;/p-1
SMILES Code
O=C(OCC1OC(C)(CCCCCCCCCCCCCCCCC)OC1)CCCCC[N+]2=C3C=CC=CC3=CC=C2.[Br-]
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 662.79 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Pons F, Touvay C, Lejeune V, Carré C, Vilain B, Broquet C, Mencia-Huerta JM, Braquet P. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig. J Lipid Mediat. 1989 Nov-Dec;1(6):329-40. PubMed PMID: 2519901. 2: Miller LG, Bazan NG, Roy RB, Clostre F, Gaver A, Braquet P. Platelet activating factor antagonists interact with GABAA receptors. Res Commun Chem Pathol Pharmacol. 1991 Nov;74(2):253-6. PubMed PMID: 1667341. 3: Domingo MT, Piro F, Broquet C, Auclair E, Chabrier PE, Braquet P. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists. Lipids. 1992 Aug;27(8):582-6. PubMed PMID: 1328798.